Benign prostatic hyperplasia Posts on Medivizor
Navigation Menu

Benign prostatic hyperplasia Posts on Medivizor

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Evaluating the effectiveness and safety of Quisqualis indica extract for the treatment of patients with lower urinary tract symptoms.

Posted by on Aug 27, 2023 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of Quisqualis indica (Rangoon creeper or Chinese honeysuckle; a type of plant) extract for the treatment of patients with lower urinary tract symptoms (LUTS). The data showed that Quisqualis indica extract was safe and effective for the treatment of these patients. Some background Benign...

Read More

Evaluating the outcomes of GreenLight laser photoselective vaporization in patients with large prostates for the treatment of benign prostatic hyperplasia.

Evaluating the outcomes of GreenLight laser photoselective vaporization in patients with large prostates for the treatment of benign prostatic hyperplasia.

Posted by on Apr 30, 2023 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the outcomes of GreenLight laser photoselective vaporization (PVP) in patients with large prostates for the treatment of benign prostatic hyperplasia (BPH). The data showed that GreenLight PVP was safe and effective in these patients. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement...

Read More

Evaluating the outcomes of single-pass versus multiple-pass during aquablation in patients with urinary symptoms due to benign prostatic hyperplasia.

Evaluating the outcomes of single-pass versus multiple-pass during aquablation in patients with urinary symptoms due to benign prostatic hyperplasia.

Posted by on Nov 22, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the outcomes of single-pass versus multiple-pass during aquablation in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The data showed that treatment with multiple passes during aquablation improved the urinary outcomes compared to a single pass in these patients. Some...

Read More

Comparing salvage and primary holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia.

Comparing salvage and primary holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia.

Posted by on Nov 5, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study compared the safety and effectiveness of salvage (S) and primary (P) holmium laser enucleation of the prostate (HoLEP) in patients with benign prostatic hyperplasia (BPH). It also evaluated what were the procedures leading to S-HoLEP in these patients. The authors concluded that S-HoLEP was similar to...

Read More

Evaluating the effectiveness of tadalafil alone, silodosin alone, and the combination of both in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Evaluating the effectiveness of tadalafil alone, silodosin alone, and the combination of both in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Posted by on Oct 16, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness of tadalafil (Cialis) alone, silodosin (Rapaflo) alone, and the combination of both in the treatment of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data showed that a combination of tadalafil plus silodosin is more effective than either drug alone in...

Read More

Evaluating the short-term functional outcomes and safety of holmium and thulium fiber laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Evaluating the short-term functional outcomes and safety of holmium and thulium fiber laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Posted by on Sep 18, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the short-term functional outcomes and safety of holmium (HoLEP) and thulium fiber laser enucleation of the prostate (ThuFLEP) treatment for patients with benign prostatic hyperplasia (BPH). The data showed that both HoLEP and ThuFLEP surgeries are similar in terms of functional outcomes and safety in these patients....

Read More

Evaluating the effectiveness of adding dutasteride to tadalafil for improving lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Evaluating the effectiveness of adding dutasteride to tadalafil for improving lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Posted by on Sep 11, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness of adding dutasteride (Avodart) to tadalafil (Cialis) for the treatment of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data showed that adding dutasteride to tadalafil is a good treatment option for improving LUTS in these patients. Some background...

Read More

Can a combination of tamsulosin and herbal medicine improve lower urinary tract symptoms due to benign prostatic hyperplasia?

Can a combination of tamsulosin and herbal medicine improve lower urinary tract symptoms due to benign prostatic hyperplasia?

Posted by on Aug 26, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study assessed the effectiveness and safety of combined therapy of tamsulosin (Flomax) and two different traditional herbal medicines in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The study showed that tamsulosin with Ryutanshakanto provided pain relief in patients with chronic...

Read More

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Does diabetes affect lower urinary tract symptoms in patients with benign prostatic hyperplasia?

Posted by on May 31, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study reviewed the effect of diabetes on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). The data suggested that LUTS were increased in patients with BPH that had diabetes compared to patients without diabetes. Some background Men above 50 years of age frequently experience LUTS due to benign...

Read More

Evaluating the effectiveness and safety of Rezum water vapor therapy in real-world patients with benign prostatic hyperplasia.

Evaluating the effectiveness and safety of Rezum water vapor therapy in real-world patients with benign prostatic hyperplasia.

Posted by on May 31, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of Rezum water vapor therapy in real-world patients with benign prostatic hyperplasia (BPH). The data showed that Rezum water vapor therapy was safe and effective in these patients. Some background Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate...

Read More

Evaluating the long-term effectiveness and safety of thulium laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Evaluating the long-term effectiveness and safety of thulium laser enucleation of the prostate treatment for patients with benign prostatic hyperplasia.

Posted by on Apr 10, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of thulium laser enucleation of the prostate (ThuLEP) treatment for patients with benign prostatic hyperplasia (BPH). The data showed that ThuLEP treatment was safe and effective over the long term in these patients. Some background BPH is the non-cancerous increase in the size...

Read More

Factors affecting long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with BPH

Factors affecting long-term dutasteride add-on treatment to alpha-adrenergic antagonist for patients with BPH

Posted by on Feb 20, 2022 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study identified clinical risk factors that resulted in the failure of dutasteride (Avodart) add-on treatment to alpha-adrenergic antagonists for patients with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). The authors concluded that an intravesical prostatic protrusion (IPP; the enlargement of the...

Read More